Quick Takeaways
- Framework Ventures IV L.P. filed SCHEDULE 13D/A for NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY).
- Disclosed ownership: 45%.
- Date of event: 16 Jan 2026.
Quoteable Key Fact
"Framework Ventures IV L.P. disclosed 45% ownership in NovaBay Pharmaceuticals, Inc. Common Stock, $0.01 par value (NBY) on 16 Jan 2026."
Beneficial ownership values are sourced from the original SEC Schedule 13D/13G filing.
See Original Filing| Name | Ownership | Shares Owned | sole voting power | shared voting power | Signature | Title | CIK |
|---|---|---|---|---|---|---|---|
| Framework Ventures IV L.P. | 45% | 56,806,080 | 0 | 56,806,080 | /s/ Michael Ernest Anderson | Michael Ernest Anderson / Authorized Signatory | 0002028474 |
| Framework Ventures Management LLC | 45% | 56,806,080 | 0 | 56,806,080 | /s/ Michael Ernest Anderson | Michael Ernest Anderson / Authorized Signatory | 0002091751 |
| Framework Ventures IV GP LLC | 45% | 56,806,080 | 0 | 56,806,080 | /s/ Michael Ernest Anderson | Michael Ernest Anderson / Authorized Signatory | 0002092591 |
| Spencer Vance | 45% | 56,806,080 | 0 | 56,806,080 | /s/ Vance Spencer | Vance Spencer | 0002092030 |
| Anderson Michael Ernest | 45% | 56,806,080 | 0 | 56,806,080 | /s/ Michael Ernest Anderson | Michael Ernest Anderson | 0002093174 |